Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
KURA

Updated 10/6/2026, 5:33 PM ET.

KURA

Kura Oncology, Inc.

Sale$88,618

Bair Teresa Brophy

Chief Legal Officer

8,442 shat $10.50Filed Sep 29, 6:30 PM ET
Filing
KURA

Kura Oncology, Inc.

Sale$111,931

FORD KATHLEEN

Chief Operating Officer

10,574 shat $10.59Filed Sep 29, 6:30 PM ET
Filing
KURA

Kura Oncology, Inc.

Sale$440,237

Leoni Mollie

Chief Medical Officer

41,250 shat $10.67Filed Sep 29, 6:30 PM ETFiling
KURA

Kura Oncology, Inc.

Sale$48,361

DOYLE THOMAS JAMES

SVP, Finance & Accounting

4,607 shat $10.50Filed Sep 29, 6:30 PM ETFiling
KURA

Kura Oncology, Inc.

Sale$345,036

Powl Brian T.

Chief Commercial Officer

32,450 shat $10.63Filed Sep 29, 6:30 PM ETFiling
KURA

Kura Oncology, Inc.

Sale$224,514

Burrows Francis

Chief Scientific Officer

20,726 shat $10.83Filed Sep 25, 4:05 PM ETFiling
KURA

Kura Oncology, Inc.

Buy$1,239,000

WILSON TROY EDWARD

President and CEO, Director

100,000 shat $12.39Filed Aug 24, 5:30 PM ETFiling
KURA

Kura Oncology, Inc.

Sale$51,663

Powl Brian T.

Chief Commercial Officer

4,345 shat $11.89Filed Aug 24, 5:30 PM ET
Filing
KURA

Kura Oncology, Inc.

Sale$397,681

Bair Teresa Brophy

Chief Legal Officer

31,487 shat $12.63Filed Aug 21, 4:30 PM ET
Filing
KURA

Kura Oncology, Inc.

Buy$1,112,000

WILSON TROY EDWARD

President and CEO, Director

100,000 shat $11.12Filed Aug 17, 4:45 PM ETFiling

Read from public SEC filings. Not financial advice.